Article | March 26, 2026

Clinical Trial Matching With AI And Large Language Models

AI Robotic brain-GettyImages-2210997075

Traditional methods for identifying clinical trial candidates often struggle to balance speed with accuracy. While rule-based systems effectively process structured data like lab results and diagnosis codes, they frequently overlook the vital context hidden within unstructured clinical notes and pathology reports. This gap often leaves site teams overwhelmed by a high volume of "matches" that lack the necessary clinical nuance, leading to resource-intensive manual screening and missed windows of opportunity for patient enrollment.

The integration of Large Language Models (LLMs) represents a significant shift in this landscape. By interpreting eligibility criteria in their original form and applying them to the entire patient record, these tools prioritize quality over quantity. Real-world applications have already demonstrated the power of this approach, showing a dramatic reduction in false positives and a substantial decrease in the screening burden for research staff. Ultimately, moving toward an AI-enhanced model allows clinical teams to move past the "data entry" phase of recruitment and focus on engaging the right patients at the most critical points in their care journey.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader